Cargando…
Clozapine Can Be the Good Option in Resistant Mania
Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not respondi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976188/ https://www.ncbi.nlm.nih.gov/pubmed/27525148 http://dx.doi.org/10.1155/2016/3081704 |
_version_ | 1782446826974085120 |
---|---|
author | Arafat, S. M. Yasir Rahman, S. M. Atikur Haque, Md. Maruful Shah, Mohsin Ali Algin, Sultana Nahar, Jhunu Shamsun |
author_facet | Arafat, S. M. Yasir Rahman, S. M. Atikur Haque, Md. Maruful Shah, Mohsin Ali Algin, Sultana Nahar, Jhunu Shamsun |
author_sort | Arafat, S. M. Yasir |
collection | PubMed |
description | Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not responding to two previous consecutive atypical antipsychotics and one typical antipsychotic was aimed at. A 17-year-old male manic patient was admitted into the psychiatry inpatient department and was nonresponsive to Risperidone 12 mg daily for 4 weeks, Olanzapine 30 mg daily for 3 weeks, and Haloperidol 30 mg daily for 3 weeks, along with valproate preparation 1500 mg daily. He was started on clozapine as he was nonresponsive to Lithium in previous episodes and did not consent to starting Electroconvulsive Therapy (ECT). He responded adequately to 100 mg clozapine and 1500 mg valproate preparation and remission happened within 2 weeks of starting clozapine. Clozapine can be a good option for resistant mania and further RCT based evidences will strengthen the options in treating resistant mania. |
format | Online Article Text |
id | pubmed-4976188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-49761882016-08-14 Clozapine Can Be the Good Option in Resistant Mania Arafat, S. M. Yasir Rahman, S. M. Atikur Haque, Md. Maruful Shah, Mohsin Ali Algin, Sultana Nahar, Jhunu Shamsun Case Rep Psychiatry Case Report Bipolar mood disorder is a mental disorder with a lifetime prevalence rate of about 1% in the general population and there are still a proportion of individuals who suffer from bipolar mood disorders that are resistant to standard treatment. Reporting clozapine responsive mania that was not responding to two previous consecutive atypical antipsychotics and one typical antipsychotic was aimed at. A 17-year-old male manic patient was admitted into the psychiatry inpatient department and was nonresponsive to Risperidone 12 mg daily for 4 weeks, Olanzapine 30 mg daily for 3 weeks, and Haloperidol 30 mg daily for 3 weeks, along with valproate preparation 1500 mg daily. He was started on clozapine as he was nonresponsive to Lithium in previous episodes and did not consent to starting Electroconvulsive Therapy (ECT). He responded adequately to 100 mg clozapine and 1500 mg valproate preparation and remission happened within 2 weeks of starting clozapine. Clozapine can be a good option for resistant mania and further RCT based evidences will strengthen the options in treating resistant mania. Hindawi Publishing Corporation 2016 2016-07-25 /pmc/articles/PMC4976188/ /pubmed/27525148 http://dx.doi.org/10.1155/2016/3081704 Text en Copyright © 2016 S. M. Yasir Arafat et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Arafat, S. M. Yasir Rahman, S. M. Atikur Haque, Md. Maruful Shah, Mohsin Ali Algin, Sultana Nahar, Jhunu Shamsun Clozapine Can Be the Good Option in Resistant Mania |
title | Clozapine Can Be the Good Option in Resistant Mania |
title_full | Clozapine Can Be the Good Option in Resistant Mania |
title_fullStr | Clozapine Can Be the Good Option in Resistant Mania |
title_full_unstemmed | Clozapine Can Be the Good Option in Resistant Mania |
title_short | Clozapine Can Be the Good Option in Resistant Mania |
title_sort | clozapine can be the good option in resistant mania |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976188/ https://www.ncbi.nlm.nih.gov/pubmed/27525148 http://dx.doi.org/10.1155/2016/3081704 |
work_keys_str_mv | AT arafatsmyasir clozapinecanbethegoodoptioninresistantmania AT rahmansmatikur clozapinecanbethegoodoptioninresistantmania AT haquemdmaruful clozapinecanbethegoodoptioninresistantmania AT shahmohsinali clozapinecanbethegoodoptioninresistantmania AT alginsultana clozapinecanbethegoodoptioninresistantmania AT naharjhunushamsun clozapinecanbethegoodoptioninresistantmania |